Evidence map›Paper›PMID 16846529›Full record

ArticleCritical care (London, England)2006

Corticosteroids influence the mortality and morbidity of acute critical illness.

Mohamed Y Rady, Daniel J Johnson, Bhavesh Patel, Joel Larson, Richard Helmers

Open access · goldAbstract readComparative Study
In one paragraph

Article in Critical care (London, England), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Underrecognized Zieve's syndrome, A case report.Annals of medicine and surgery (2012) · 2021
    Article
  6. Review
  7. Review
  8. Zieve syndrome in acute alcoholic hepatitis.Proceedings (Baylor University. Medical Center) · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Corticosteroid therapy in acute respiratory distress syndrome.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2013
    Review
  13. Article
  14. Corticosteroids and erythropoeitin-receptor agonists.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2008
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mohamed Y RadyDepartment of Critical Care Medicine, Mayo Clinic College of Medicine, Mayo Clinic Hospital, Mayo Clinic, Phoenix, Arizona, USA. editorial@ccforum.com
Daniel J Johnson
Bhavesh Patel
Joel Larson
Richard Helmers
Mayo Clinic Hospital · USMayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionUse of corticosteroids for adrenal supplementation and attenuation of the inflammatory and immune response is widespread in acute critical illness. The study hypothesis was that exposure to corticosteroids influences the mortality and morbidity in acute critical illness.

methodsThis case-control retrospective study was performed in a single multidisciplinary intensive care unit at a tertiary care institution and consisted of 10,285 critically ill patients admitted between 1 January 1999 and 31 December 2004. Demographics, comorbidities, acute illness characteristics including severity measured by Sequential Organ Failure Assessment, concurrent medications, therapeutic interventions and incidence of infections were obtained from electronic medical records, were examined with multiple regression analysis and were adjusted for propensity of corticosteroid exposure. The primary outcome was hospital death, and the secondary outcome was transfer to a care facility at hospital discharge.

resultsCorticosteroid exposure in 2,632 (26%) patients was characterized by younger age, more females, higher Charlson comorbidity and maximal daily Sequential Organ Failure Assessment scores compared with control patients. Corticosteroids potentiated metabolic and neuromuscular sequels of critical illness with increased requirements for diuretics, insulin, protracted weaning from mechanical ventilation, need for tracheostomy and discharge to a care facility. Early exposure to corticosteroids predisposed to recurrent and late onset of polymicrobial and fungal hospital-acquired infections. Corticosteroids increased the risk for death or disability after adjustments for comorbidities and acute illness characteristics.

conclusionCorticosteroids increased the risk for death or disability in critical illness. Hospital-acquired infections and metabolic and neuromuscular sequels of critical illness were exacerbated by corticosteroids. Careful appraisal of the indications for use of corticosteroids is necessary to balance the benefits and risks from exposure in acute critical illness.

Indexed as

Acute DiseaseAdrenal Cortex HormonesAdultAgedAged, 80 and overCase-Control StudiesCohort StudiesCommunicable DiseasesComorbidityCritical IllnessCross InfectionFemaleHumansMaleMiddle AgedMorbidityAdrenal Cortex Hormones

Identifiers

PMID16846529
PMCPMC1750970
OpenAlexW1837154146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.